On August 21, 2023, Xenodata Lab. Co., Ltd. closed the transaction. The company amended the terms of the transaction.

The company received additional ¥180,000,000 in equity funding. The aggregate gross proceeds of ¥485,000,000 in funding. The additional funding included participation from new investors, Ibis Shin Seicho Fund No.

6, managed by Ibis Capital Partners, Inc., Investment Arm, meinan M&A co.,ltd., Sagin Capital & Consulting Co., Ltd., Kagawa Securities Co., Ltd. and OKB Capital Co., Ltd.